CDMI - FDA SMART Workshop
CDMI - FDA SMART Workshop
批准号:
1829162
负责人:
Jeffrey Lotz
金额:
$1.92万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-04-15 至 2018-09-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The NSF IUCRC Center for Disruptive Musculoskeletal Innovations (CDMI) is hosting a public workshop in collaboration with the Food and Drug Administration (FDA) entitled "Orthopedic Sensing, Measuring, and Advanced Reporting Technology (SMART) Devices". The goal of the workshop is to: 1) to gain better understanding of current state and future possibilities of Orthopedic SMART device technology; and 2) begin to identify/establish appropriate regulatory framework to promote use of the technology and protect public health. Public input and feedback gained through this workshop may aid in the efficient development of innovative, safe and effective, orthopaedic SMART devices, for better patient care.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase II IUCRC at UC San Francisco: Center for Disruptive Musculoskeletal Innovations (CDMI)
-
批准号:1916629
-
项目类别:Continuing Grant
-
资助金额:$50.0万
-
财政年份:2019
-
负责人:Jeffrey Lotz
-
依托单位:
I/UCRC: Technology Innovation for Novel Cost-reducing and Quality-enhancing Musculoskeletal Therapies
-
批准号:1361975
-
项目类别:Continuing Grant
-
资助金额:$52.05万
-
财政年份:2014
-
负责人:Jeffrey Lotz
-
依托单位:
Planning Grant: I/UCRC for technology innovation for novel cost-reducing and quality-enhancing musculoskeletal therapies
-
批准号:1265896
-
项目类别:Standard Grant
-
资助金额:$3.84万
-
财政年份:2013
-
负责人:Jeffrey Lotz
-
依托单位:
国内基金
海外基金
FDA上市药物库筛选鉴定靶向治疗ARID1A缺陷型结直肠癌的合成致死效应及分子机制研究
-
批准号:82373165
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:李爱民
-
依托单位:
多维互质结构FDA雷达稀疏空时距自适应处理研究
-
批准号:61771317
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2017
-
负责人:阳召成
-
依托单位:
基于FDA标记畸胎瘤细胞联合人胎盘屏障体外模型建立中药胚胎毒性评价体系的研究
-
批准号:81573740
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2015
-
负责人:宋殿荣
-
依托单位: